News: Portfolio 2007

Agile Therapeutics Closes $17.6M Series E Venture Financing

Plans to Accelerate Development of Women’s Healthcare Portfolio

Princeton, NJ – December 2007 – Agile Therapeutics, Inc., a specialty pharmaceutical company focused on the development of innovative women’s healthcare products, today announced that it has raised USD $5.6 million in an extension of its Series E financing round, bringing the total of the round to USD $17.6 million. As part of the extension, current investors including The Hillman Company, ProQuest Investments, TLVentures and Novitas (formerly PA Early Stage Partners) all participated in the round.


Thomas M. Rossi, Ph.D., President & CEO of Agile Therapeutics commented on the announcement, “We are delighted with the decision by our current investors to continue to support the clinical development of the company’s low estrogen dose transdermal patch, and to fund the growth of our women’s healthcare portfolio. This commitment